Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Meilleure Health International Industry Group Limited ( (HK:2327) ).
Meilleure Health International Industry Group Limited has agreed to acquire the entire equity interest in Jiangsu Yide from U-Home Group and individual vendor Tan Wensheng for RMB124.77 million (about HK$137 million), in a deal that will make Jiangsu Yide a wholly owned subsidiary with its financial results fully consolidated into the group’s accounts. The transaction is classified as a discloseable and connected transaction under Hong Kong listing rules because U-Home Group and Jiangsu Yide are associates of controlling shareholder and executive director Mr. Zhou, who is also providing a personal guarantee for the vendors’ obligations; as a result, the deal requires independent shareholders’ approval at a special general meeting, with a circular containing further details, independent advice and a valuation report to be sent to shareholders by 6 February 2026.
The most recent analyst rating on (HK:2327) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Meilleure Health International Industry Group Limited stock, see the HK:2327 Stock Forecast page.
More about Meilleure Health International Industry Group Limited
Average Trading Volume: 2,735,066
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.06B
For detailed information about 2327 stock, go to TipRanks’ Stock Analysis page.